NJ State Employees Deferred Compensation Plan’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,358
Closed -$230K 10
2025
Q3
$230K Buy
+2,358
New +$190K 0.03% 391
2024
Q4
Sell
-2,358
Closed -$247K 463
2024
Q3
$247K Hold
2,358
0.03% 404
2024
Q2
$335K Hold
2,358
0.04% 352
2024
Q1
$263K Hold
2,358
0.03% 392
2023
Q4
$306K Hold
2,358
0.04% 373
2023
Q3
$384K Hold
2,358
0.06% 314
2023
Q2
$432K Hold
2,358
0.06% 304
2023
Q1
$314K Buy
+2,358
New +$277K 0.05% 368
2014
Q1
Sell
-2,358
Closed -$23K 392
2013
Q4
$23K Hold
2,358
﹤0.01% 428
2013
Q3
$20K Hold
2,358
﹤0.01% 429
2013
Q2
$17K Buy
+2,358
New +$13.7K ﹤0.01% 433

Other funds holding ACLS

NJ State Employees Deferred Compensation Plan's ACLS Position: Q4 2025 in Review

NJ State Employees Deferred Compensation Plan sold out of Axcelis (ACLS) in Q4 2025, closing a stake of 2,358 shares — an estimated $230K sold.

NJ State Employees Deferred Compensation Plan first reported a position in ACLS in Q2 2013 and held it in 11 quarters. The position peaked at $432K in Q2 2023. 370 funds tracked by Wall St. Rank hold ACLS as of Q4 2025.

  • NJ State Employees Deferred Compensation Plan reported no remaining Axcelis position as of Q4 2025 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 2,358 Axcelis shares in Q4 2025, an estimated $230K.
  • NJ State Employees Deferred Compensation Plan first reported a position in Axcelis in Q2 2013 and held it in 11 quarters.
  • NJ State Employees Deferred Compensation Plan's Axcelis position peaked at $432K in Q2 2023.
  • 370 funds tracked by Wall St. Rank held Axcelis as of Q4 2025.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2025.